WHO recommends “not to use” ivermectin for Covid-19 – News

On the other hand, its American counterpart, the FDA, explains on its website why ivermectin should not be used.

It is a commonly used antiparasitic drug that is widely promoted on social networks but the WHO expert group assured that the data from clinical studies to measure its effectiveness against Covid-19 were inconclusive.

/ Home of the embed code /

/ End of embed code /

“Our recommendation is not to use ivermectin for patients with Covid-19, regardless of the level of severity or the duration of the symptoms,” said Janet Díaz, head of the clinical response team for the novel coronavirus from the UN agency.

Díaz pointed out that the The only exception to this recommendation, based on the current state of research, is for clinical trials., reported the agency AFP.

WHO experts drew their conclusions from 16 randomized clinical trials with 2,400 participants, some of which compared ivermectin with other drugs.

Bram Rochwerg, researcher at McMaster University in Canada and member of the WHO panel that conducted the assessment, said in this regard that the number of studies comparing ivermectin with a placebo “is much higher. small”.

Both Díaz and Rochwerg assured that the recommendations are “alive” and that they will be updated as new research progresses.

Ivermectin, for veterinary and human use, is used against parasites such as scabies, lice or those that cause onchocerciasis.

Sin embargo, un estudio australiano publicado a principios de 2020 observed una eficacia in vitro, es decir en el laboratorio, de la ivermectina sobre el Sars-CoV-2, el virus that provoca la Covid-19, lo que generó su difusión en algunos the countries.

Ivermectin shares certain characteristics with hydroxychloroquine, which are advocated by some doctors and politicians, despite the fact that its effectiveness has not been proven and a large clinical trial has concluded that it has no effect. .